2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 217.646 | 219.921 | 191.198 | 203.734 | 213.019 | 201.454 | 183.343 | 156.735 | 147.560 | 155.908 |
Total Income - EUR | 217.661 | 219.935 | 199.438 | 203.782 | 213.026 | 201.479 | 183.455 | 157.598 | 147.562 | 155.963 |
Total Expenses - EUR | 201.241 | 207.764 | 183.319 | 189.647 | 193.561 | 185.719 | 168.595 | 151.826 | 143.019 | 152.923 |
Gross Profit/Loss - EUR | 16.420 | 12.171 | 16.120 | 14.135 | 19.465 | 15.760 | 14.860 | 5.772 | 4.543 | 3.040 |
Net Profit/Loss - EUR | 13.769 | 10.182 | 13.439 | 12.271 | 17.335 | 13.746 | 13.169 | 4.196 | 3.103 | 1.512 |
Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Farma Prest Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 10.680 | 10.031 | 9.324 | 24.419 | 19.046 | 13.848 | 8.847 | 5.719 | 5.186 | 4.622 |
Current Assets | 212.746 | 230.115 | 145.442 | 136.457 | 165.204 | 161.386 | 183.210 | 174.065 | 92.010 | 99.541 |
Inventories | 113.727 | 91.492 | 103.966 | 99.709 | 105.201 | 104.646 | 118.719 | 118.069 | 67.529 | 72.756 |
Receivables | 20.054 | 13.571 | 16.043 | 21.648 | 28.590 | 19.098 | 23.910 | 17.856 | 22.765 | 21.915 |
Cash | 78.965 | 125.052 | 25.433 | 15.101 | 31.413 | 37.642 | 40.581 | 38.139 | 1.716 | 4.870 |
Shareholders Funds | 152.904 | 164.362 | 89.387 | 78.254 | 94.153 | 106.075 | 117.233 | 118.830 | 48.242 | 49.354 |
Social Capital | 382 | 385 | 381 | 374 | 367 | 360 | 354 | 346 | 347 | 346 |
Debts | 70.523 | 78.383 | 65.380 | 82.623 | 90.097 | 69.158 | 74.824 | 60.954 | 48.955 | 54.809 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Farma Prest Srl